NCT00331760 · OUTCOME
Rate of Local-regional Failure at Five Years
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- From registration to five years.
What was measured
Local-regional failure time is defined as time from registration to date of local-regional failure (any failure in the treatment field, which will be the pelvis only), death without local-regional failure (competing risk), or last known follow-up (censored). Local-regional failure rates are estimated by the cumulative incidence method.
Analysis population: Eligible patients who started study treatment
Groups in this outcome
Endometrial Cancer: IMRT
Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
| Group | Source count |
|---|---|
| Endometrial Cancer: IMRT | 43 |
| Cervical Cancer: IMRT + Chemotherapy (Cisplatin) | 40 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Endometrial Cancer: IMRT | 5 | Not reported | 1 | 14 | Not reported |
| Cervical Cancer: IMRT + Chemotherapy (Cisplatin) | 8 | Not reported | 2 | 19 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 1
- upper Limit
- 14
- value
- 5
- group Id
- OG001
- lower Limit
- 2
- upper Limit
- 19
- value
- 8
- denoms
- counts
- group Id
- OG000
- value
- 43
- group Id
- OG001
- value
- 40
- units
- Participants
- description
- Local-regional failure time is defined as time from registration to date of local-regional failure (any failure in the treatment field, which will be the pelvis only), death without local-regional failure (competing risk), or last known follow-up (censored). Local-regional failure rates are estimated by the cumulative incidence method.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
- id
- OG000
- title
- Endometrial Cancer: IMRT
- description
- Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
- id
- OG001
- title
- Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
- param Type
- NUMBER
- population Description
- Eligible patients who started study treatment
- reporting Status
- POSTED
- time Frame
- From registration to five years.
- title
- Rate of Local-regional Failure at Five Years
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle